Pericardial effusion and cardiac tamponade have been described as GVHD manifestations in the post transplant period. Direct evidence of GVHD-related TCR or B-cell receptor clones in patients with pericardial effusion has never been described. Using several methods, including FACS and spectratyping analysis to assess T-and B-cell clonality and to quantify TCR excision circles to assess newly thymus-derived T cells, we were able to show expansion of oligoclonal T-cell populations and the possible presence of early/premature B cells in the pericardial effusion but not in peripheral mononuclear cells. This may explain the presentation of an isolated GVHD manifestation.
Introduction
BMT is an intensive procedure for treating certain diseases, including SCID. 1 This life-saving procedure carries a significant risk of serious complications. Pericardial effusion and cardiac tamponade have been described in the post transplant period and have been usually associated with toxicity of medications, veno-occlusive disease, infections, cardiac insufficiency, tumor relapse or GVHD. [2] [3] [4] The latter is considered the most common complication after BMT. 5 The underlying mechanism of GVHD resembles those of several autoimmune diseases. Accordingly, B-cell dysregulation with autoantibodies to cell surface and intracellular antigens together with donor T cells reacting with self-components of recipients have been suggested as having a pivotal function in its pathogenesis. 6 Clinically significant pericardial effusion and cardiac tamponade as a GVHD manifestation in pediatric patients after BMT have been described 4 and have been usually associated with polyserositis disease, CMV infection, heart failure or part of extensive GVHD. 4, 7 Pericardial effusion and cardiac tamponade as a solitary manifestation of GVHD have been rarely reported. 2 Here, we describe a case of an isolated pericardial effusion in a patient with SCID after allogeneic BMT. Enhanced clonal expansion and reduced newly derived thymic T cells in the pericardial effusion but not in the peripheral blood made diagnosis of a GVHD manifestation highly likely.
Methods

Immune function
Assessment of cell-surface markers of PBMC and pericardial effusion was performed using immunofluorescent staining and flow cytometry (Epics V; Beckman Coulter, Hialeah, FL, USA) with Abs purchased from Coulter.
Quantitation of TCR genes
Representatives of specific TCR-V (variable) b families were detected and quantified using flow cytometry (Becton Dickinson, Calibur, Franklin Lakes, NJ, USA) and referred to the Quick Reference Card according to the manufacturer's (Beckman Coulter) instructions. TCR-Vg rearrangements were amplified by PCR according to the standardized Biomed 2 protocol. For GeneScan analyses, fluorescence-labeled Vg primers were used in PCRs as described in the Biomed 2 protocol. Fluorescence-labeled PCR amplificate (1 ml of each) was added to a mixture of 8.5 ml deionized formamide and 0.5 ml GeneScan 500TM Rox internal lane standard (PE Biosystems, Weiterstadt, Germany).
Quantitation of B-cell receptor genes
Rearrangements of the immunoglobulin heavy chain (IGH) were identified using PCR according to the standardized Biomed 2 protocol. For GeneScan analyses, fluorescence-labeled Vh primers were used in PCRs as described in the Biomed 2 protocol. Fluorescencelabeled PCR amplificate (1 ml of each) was added to a mixture of 8.5 ml deionized formamide and 0.5 ml GeneScan 500TM Rox internal lane standard (PE Applied Biosystems).
Analysis of TCR excision circles
Analysis was performed using DNA extracted from the patient's PBMC or pericardial effusion. The amount of signal joint TCR excision circle (TREC) copies per DNA content was determined by real-time quantitative PCR, as previously described. 8 In brief, genomic DNA was isolated from body effusion after Ficoll-Hypaque gradient centrifugation and extracted with a Promega Wizard genomic purification kit (Promega, Madison, WI, USA) according to the manufacturer's instructions. Amplification reactions (25 ml) contained 0.5 mg of genomic DNA, 12.5 ml of TaqMan universal PCR master mix (PerkinElmer/ Applied Biosystems, Foster City, CA, USA), and the appropriate primers and probes. PCR (2 min at 50 1C followed by 95 1C for 10 min, then 40 cycles at 95 1C for 15 s and 60 1C for 1 min) was carried out in ABI PRISM 7900 Sequence Detector TaqMan system (Applied Biosystems, Rotkreuz, Switzerland). The number of TRECs in a given sample was estimated by comparing the cycle threshold value obtained with a standard curve derived from PCRs performed with 10-fold serial dilutions of an internal standard kindly provided by Dr Daniel Douek (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA).
Case report
An 18-month-old boy with RAG2 deficiency SCID underwent allogeneic BMT from an HLA-identical relative. Conditioning consisted of fludarabine, treosulfan and thiotepa. CsA and MTX were used as GVHD prophylaxis. A pretransplant echocardiogram revealed normal heart structure. Engraftment (defined as a peripheral neutrophil count 40.5 Â 10 9 /l) was noted on day þ 16. During the post transplant period, the patient suffered from Escherichia coli sepsis (day þ 30) and mild acute skin GVHD (day þ 45), which were successfully controlled with antibiotics and steroids, respectively. CsA was stopped on day þ 100, and there was no further clinical and laboratory evidence of GVHD. Chimerism, evaluated by analysis of microsatellite variable numbers of tandem repeats on whole blood, was compatible with full donor chimerism from day þ 100. T-cell immune reconstitution gradually increased, as determined by the numbers of T cells, response to mitogens, expression of a diverse TCR repertoire and thymus output (TRECs). The patient remained on g-globulin replacement therapy because of late B-cell immune reconstitution. On day þ 300, the patient developed respiratory distress and signs of cardiac tamponade. The chest X-ray showed cardiomegaly and a small right-sided pleural effusion.
Echocardiogram confirmed the presence of a large pericardial effusion. The patient was started on steroids and the pericardial effusion was drained. The peripheral blood count and CPK values were normal. The ESR was elevated and antinuclear Abs were highly positive, suggestive of an autoimmune phenomenon. The pericardial effusion was exudative and contained mesothelial cells and lymphocytes. Lactate dehydrogenase was 5.6 g per 100 ml and glucose 85 mg per 100 ml. PCR infection workup, including CMV, EBV, adenovirus, enterovirus and influenza virus, was negative in both the pericardial effusion and PBMC. The patient responded very well to drainage and was kept on steroids for 1 month. A followup echocardiogram 1 month later showed no evidence of effusion.
Results
Immune markers in peripheral blood and pericardial effusion The total peripheral lymphocyte count was 3.546K/mm 3 with normal numbers of the CD3 þ , CD4 þ , CD8 þ , CD20 þ and CD56 þ cells (2482, 1773, 638, 815 and 71 cells per ml, respectively). However, the pericardial effusion contained predominantly CD8 þ cells with a reverse ratio of CD4/CD8 (0.89 compared with 2.77 in the peripheral blood) and no CD20 þ cells. Most of the CD3 þ cells in the PBMC were naive T cells and not activated or memory cells (CD45RA 76% and CD45RO 14%, respectively). The only sign of T-cell activation in the peripheral blood was a slight elevation in CD4 þ CD25 þ cells (4%) compared with the pericardial effusion (2%). Lymphocytes (3%) in the pericardial effusion were CD3 þ CD56 þ (natural killer T (NKT) cells), whereas there were none in the PBMC.
Lymphocyte clonality and TRECs in peripheral blood and pericardial effusion To gain more insight into the origin of the patient's lymphocytes in the pericardial effusion and to compare this finding to his PBMC, we assessed lymphocyte clonality by analyzing the TCR-Vb repertoire, TCR-Vb spectratyping and B-cell receptor (BCR) spectratyping. The analysis of the TCR-Vb repertoire in the patient's PBMC revealed an almost entirety normal presentation with a slight elevation of TCR-Vb (13.2) and a reduction of TCR-Vb (7.2) (Figure 1a) . The TCR-Vb repertoire in the patient's pericardial effusion revealed a different repertoire, with three predominant clones (TCR-Vb 14, 20 and 21.3) and reduced expression of the TCR-Vb (13.2) (Figure 1b) . To better define the lymphoid clonality of the pericardial effusion, we also performed PCR analysis of the TCRg gene rearrangement that represents the 'prototype' of restricted repertoire targets. The TCRg gene rearrangement in the pericardial effusion consisted of clonal TCR-Vg9/2 and restricted TCR-VgF1 distribution compared with the TCR-Vb distribution observed in patient's PBMC. We also examined the BCR repertoire to determine B-cell clonality in the pericardial effusion (Figure 1c) . Clear clonal expression of the detected rearrangements of IGH BCR was observed in the pericardial effusion in the two consensus primers that were examined, whereas the BCR repertoire in the PBMC was normally expressed in a near Gaussian distribution.
TRECs quantification (copies per 0.5 mg DNA) in the pericardial effusion was undetectable, whereas 100 TRECs copies were detected in the PBMC. This observation is consistent with our assumption that enhanced lymphocyte proliferation resulting in clonal expansion diluted the TRECs in the pericardial effusion compared with the peripheral blood.
Discussion
We describe a unique clinical presentation consisting of pericardial effusion and cardiac tamponade in a pediatric patient after BMT. The immunological findings of the pericardial effusion, together with the negative extensive infectious workup, lack of drug toxicity and cardiac insufficiency, are highly suggestive of a GVHD manifestation. Other presentations of pericardial effusion and cardiac tamponade usually have completely different mechanisms. 3 Similar to previous studies, 9, 10 we found infiltration of mainly CD8 þ and HLA-DR þ , which indicates the function of cytotoxic T cells in inducing chronic GVHD. Interestingly, the pericardial effusion in our patient also contained a higher level of CD3 þ CD56 þ , suggestive of the presence of NKT cells. 11 Recent studies have shown that NKT cells have protective functions in GVHD, in which complicated immunologic processes are involved. 12 The presence of a large amount of these cells in the pericardial effusion in our patient could be explained as a mechanism for controlling the GVHD. However, NKT cells produce mainly IL-4 and IFNg that are different from the cytokine milieu of the effusion that had been reported in a similar case of GVHD-associated pericardial effusion. 10 In that case, the pericardial effusion contained mainly TNFa and sFAS and lacked IFNg, IL-2, IL-4 and IL-10.
Direct evidence of GVHD-related TCR clones in a patient with pericardial effusion has never been described. Analysis of TCR clonality is of value in the diagnosis of T-cell immunodeficiencies and autoimmune diseases where there is expansion of certain T-cell clones evoked by malignancy or repeated exposure to a specific antigen or superantigen. 9 Indeed, GVHD is characterized by dominance of oligoclonal T-cell populations, reflecting specific antigen-driven immune responses. 13 We used different methods that included FACS analysis and TCR spectratyping to evaluate T-cell clonality in the pericardial effusion and PBMC of our patient. We also examined BCR clonality. The presence of a skewed BCR repertoire in the PCR assay despite the lack of CD20 þ cells in the flow cytometry assay is highly suggestive of the presence of early/premature B cells that lack CD20 expression and/or more sensitive mode of detection. Taken together, our patient had shown predominant lymphocyte clones in the pericardial effusion but not in his PBMC, findings that would explain the present of a solitary GVHD manifestation not involving other organs. We suggest that the expansion of these GVHD-related clones occurred mainly in the heart in response to some yet unknown self-antigen. In line with this assumption, TRECs (considered as being newly thymus-derived T cells) in the pericardial effusion were undetectable whereas in the PBMC were present, suggestive of local clonal expansion. Numerous dynamic processes, such as thymic activity and differentiation of TREC-containing cells into a more mature phenotype, influence TREC measurements.
14 In our case, we assume that enhanced lymphocyte proliferation resulting in clonal expansion diluted the TRECs in the pericardial effusion but not in the PBMC.
The expansion of certain TCR clones may also represent skewing toward pathogen exposure, and not only be evidence of self-antigens and autoimmunity. An extensive infection workup was, however, negative in both pericardial effusion and PBMC. Transient mixed chimerism has been suggested to have an important function in the pathogenesis of chronic GVHD, leading to the generation of additional alloreactive T-cell clones, 10 but chimerism from the lymphocytes obtained from both the pericardial effusion and the PBMC of our patient were of donor origin.
To summarize, we describe a case of pericardial effusion with expansion of oligoclonal T-cell populations and the possible presence of early/premature B cells as a manifestation of GVHD. We assume this reflects specific selfantigen-driven immune responses. The function of NKT cells in controlling this immune response needs further investigation.
